EP Patent

EP3033334A1 — Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof

Assigned to Constellation Pharmaceuticals Inc · Expires 2016-06-22 · 10y expired

What this patent protects

Agents of formulas (l)/(ll)/(lll) for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.

USPTO Abstract

Agents of formulas (l)/(ll)/(lll) for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.

Drugs covered by this patent

tazemetostat-hydrobromide (TAZEMETOSTAT HYDROBROMIDE)

Patent Metadata

Patent number: EP3033334A1
Jurisdiction: EP
Classification: —
Expires: 2016-06-22
Drug substance claim: No
Drug product claim: No
Assignee: Constellation Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.